ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

GDR Genedrive Plc

1.675
0.00 (0.00%)
21 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Genedrive Plc LSE:GDR London Ordinary Share GB00B1VKB244 ORD 1.5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.675 1.65 1.70 1.725 1.625 1.68 14,710,507 08:49:21
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Coml Physical, Biologcl Resh 55k -5.15M -0.0095 -1.76 9.07M
Genedrive Plc is listed in the Coml Physical, Biologcl Resh sector of the London Stock Exchange with ticker GDR. The last closing price for Genedrive was 1.68p. Over the last year, Genedrive shares have traded in a share price range of 1.425p to 17.75p.

Genedrive currently has 543,141,481 shares in issue. The market capitalisation of Genedrive is £9.07 million. Genedrive has a price to earnings ratio (PE ratio) of -1.76.

Genedrive Share Discussion Threads

Showing 6801 to 6823 of 26700 messages
Chat Pages: Latest  276  275  274  273  272  271  270  269  268  267  266  265  Older
DateSubjectAuthorDiscuss
15/2/2021
07:12
Gibso6767, what utter rubbish.It may mirror NCYT but needs revenue to do that which is very likely to be good dealing with BC.I have not seen ANYONE say it can rise that well without it.
hooded claw
15/2/2021
07:06
ODX directors cashing in ....
amaretto1
14/2/2021
20:07
There are not that many shares in issue so my concern is that many believe that this may mirror and eclipse Novacyt but just by buying alone rather than numbers to underpin a share price.
Hoping for more institutional buyers

gibso6767
14/2/2021
19:31
Hazl, are you French?.
thehitman1
14/2/2021
18:53
Expecting FDA announcement this week
swerves1
14/2/2021
18:09
Yes for years, and a capacity to quickly deploy a test for new variants, or completely new viruses will be needed, along with the commercial vehicle to quickly convert a testing solution to testing capability.
hodhasharon
14/2/2021
17:56
There will be the need for these tests for years I agree.
hazl
14/2/2021
17:41
Red hot sector and people selling on a slight pullback and whim, minimum £4 to start with, look at ncyt to see what can be achieved
milliecusto
14/2/2021
14:47
“I wouldn't be taking much notice of posters comments about 300-350”

Why? Most of the figures professionally produced at circa 500-550p are based on capacity, demand, and varying degrees of profit per test.

Some of the comments on here suggest you don’t know the business you’re invested in, or the magnitude of the recent partnerships. The large players will take your shares from you at a discount because they know you’ll question your own investment at the slightest of pullbacks or shakes.

hodhasharon
14/2/2021
14:03
Nicely said ! Yes that makes sense. I have done a lot of research on this and I agree the 300 350 mark is of limits but 200 certainly achievable. Bough in again at 125 so looking for the 170 and be happy to sell again. Certainly hope it's hits that mark :)
rayj1
14/2/2021
13:09
Rayj1, In relation to your earlier post i can see exactly where you are coming from. My own experience here is that GDR were on my watchlist and when they started climbing rapidly from under 50c at the end of Jan i paid closer attention and eventually bought in at 70. Obviously i consider these a high risk stock so once they reached 151 i took out my initial investment. I still think these have farther to go but would be interested in the next RNS and agree that from here its all about sales. In the short term i wouldn't be taking much notice of posters comments about 300-350 etc But would be very happy to hit 200 myself and then review again. As Hazl says this is a very attractive sector at the moment and there are other companies to consider as well so i am spreading my risk FAB and BRH are 2 examples worth looking at. Always be happy to take profits and never risk too much on shares with "potential" and always do your own research. All IMHO
krutt
14/2/2021
12:53
I like the seeming honesty that has developed in this board.


4777 Pugugly.

I am in exactly the same position and a good post.

hazl
14/2/2021
12:43
cut and paste merchant !!!
m0riarty
14/2/2021
12:41
Ha I wondered.
Thanks.

hazl
14/2/2021
12:40
Reference to earlier post.


'Hepatitis C is a virus that can infect the liver. If left untreated, it can sometimes cause serious and potentially life-threatening damage to the liver over many years.

But with modern treatments, it's usually possible to cure the infection, and most people with it will have a normal life expectancy.

It's estimated around 215,000 people in the UK have hepatitis C.'

NHS

hazl
14/2/2021
12:38
Gold ore. From the Gadir mine in Azerbaijan.
:)
Video

jbravo2
14/2/2021
12:16
Jbravo what are you holding in your profile picture? 8-)
hazl
14/2/2021
12:13
You're welcome.
Take care.

hazl
14/2/2021
11:17
Thank you makes sense. I am not new. We but not as experienced as many on here. So thank you :)
rayj1
14/2/2021
10:27
U can have every make of Car on a Car lot .....If you don't sell one ... u can't pay the rent !!!
amaretto1
14/2/2021
10:23
Did you know that genedrive is involved with detection of HVC?

See above.
This is a horrible disease and can really help people if it is found early.

hazl
14/2/2021
10:15
Eh ? .... the market cap has doubled !!
amaretto1
14/2/2021
10:12
Only sentiment drives the in either direction, nothing more.
countdracula55
Chat Pages: Latest  276  275  274  273  272  271  270  269  268  267  266  265  Older